Jessica Donington

1 month ago | jamanetwork.com | Ernest Chan |Jessica Donington

The CROSS trial demonstrated superior survival with the use of neoadjuvant chemoradiotherapy and surgery compared to surgery alone and demonstrated an overall survival benefit through 10 years.1,2 As such, this is the standard treatment approach for locally advanced esophageal squamous cell carcinoma (ESCC).

Mar 27, 2024 | ctsnet.org | Jessica Donington

CTSNet recently hosted the first webinar in the ESTS Women in General Thoracic Surgery Committee and the Women in Thoracic Surgery webinar series, in which experts discussed women as leaders in cardiothoracic surgery. Watch the recording below for more.